APA (7th ed.) Citation

Ravaud, A., Trufflandier, N., Ferrière, J., Debled, M., Palussière, J., Cany, L., . . . Mathoulin-Pélissier, S. (2003). Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: A phase II trial. British Journal of Cancer, 89(12), 2213. https://doi.org/10.1038/sj.bjc.6601419

Chicago Style (17th ed.) Citation

Ravaud, A., et al. "Subcutaneous Interleukin-2, Interferon Alpha-2b and 5-fluorouracil in Metastatic Renal Cell Carcinoma as Second-line Treatment After Failure of Previous Immunotherapy: A Phase II Trial." British Journal of Cancer 89, no. 12 (2003): 2213. https://doi.org/10.1038/sj.bjc.6601419.

MLA (9th ed.) Citation

Ravaud, A., et al. "Subcutaneous Interleukin-2, Interferon Alpha-2b and 5-fluorouracil in Metastatic Renal Cell Carcinoma as Second-line Treatment After Failure of Previous Immunotherapy: A Phase II Trial." British Journal of Cancer, vol. 89, no. 12, 2003, p. 2213, https://doi.org/10.1038/sj.bjc.6601419.